MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 24 filers reported holding MERUS N V in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,160,250 | -22.8% | 75,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,502,250 | -11.5% | 75,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,698,000 | -14.4% | 75,000 | 0.0% | 0.00% | – |
| Q1 2022 | $1,983,000 | -16.9% | 75,000 | 0.0% | 0.00% | – |
| Q4 2021 | $2,385,000 | +1217.7% | 75,000 | +558.3% | 0.00% | – |
| Q2 2017 | $181,000 | -62.9% | 11,393 | -43.0% | 0.00% | – |
| Q1 2017 | $488,000 | -38.2% | 20,000 | -46.5% | 0.00% | – |
| Q4 2016 | $790,000 | -14.0% | 37,400 | -51.7% | 0.00% | – |
| Q3 2016 | $919,000 | +186.3% | 77,400 | +93.5% | 0.00% | – |
| Q2 2016 | $321,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 893,527 | $23,625,000 | 21.94% |
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $42,304,000 | 11.46% |
| COMMODORE CAPITAL LP | 1,816,421 | $48,026,000 | 10.73% |
| MPM BioImpact LLC | 919,482 | $24,311,000 | 6.52% |
| Aquilo Capital Management, LLC | 1,261,534 | $33,355,000 | 4.90% |
| BVF INC/IL | 4,135,071 | $109,331,000 | 4.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 324,719 | $8,586,000 | 3.55% |
| TCG Crossover Management, LLC | 300,000 | $7,932,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 235,500 | $6,227,000 | 2.91% |
| Opaleye Management Inc. | 338,000 | $8,937,000 | 2.78% |